• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

    Transitioning from Clinical Production to Commercial Manufacturing

    Clinical Trial Technology

    Regenerative Medicine: Overcoming the supply chain challenges

    The Future of the Pharmaceutical Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Northwest Biotherapeutics Expands Management Team
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Amgen Selects Location For R&D Facility

    Catalent Launches Clinical Trial Planning Service

    CatSci Expands Capabilities with Lab Expansion

    PCI Pharma Services Invests in Tredegar, UK Site

    Avantor Boosts Biopharmaceutical Innovation in China
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence

    Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

    Stevanato Group Begins Construction on TEC

    CSafe Global Expands Packaging Portfolio

    CSafe Global Opens Service Centers in Switzerland and Sweden
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Charles River Provides Access to Cosmic Antibody Library
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pelican BioThermal Achieves ISO Accreditation

    PhRMA Appoints Federal Advocacy SVP

    CureVac Granted Mfg. Authorization for GMP Production Suite

    Metrics Completes Japanese Regulatory Inspection

    Samsung Biologics Achieves ISO27001 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Vetter Pharma International GmbH

    Ajinomoto Bio-Pharma Services

    Baxter BioPharma Solutions

    Federal Equipment Company

    CCRM
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vetter Pharma International GmbH

    Reed-Lane, Inc.

    Flow Sciences, Inc.

    Baxter BioPharma Solutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Fujifilm Expands Gene Therapy Capabilities

    Investing $55mn in gene therapy process and analytical development capabilities with the addition of new dedicated laboratories.

    Related CONTENT
    • Vetter Works Towards a Sustainable Energy Supply
    • Fujifilm Opens Life Science Office in Massachusetts
    • Fujifilm to Invest $10M in Continuous Processing Facility
    • FUJIFILM Irvine Scientific to Construct Manufacturing Site in Europe
    • Regis Technologies Expands Capabilities
    11.15.19
    Fujifilm Diosynth Biotechnologies (FDB), a global biologics contract development and manufacturing organization (CDMO), is expanding its gene therapy services with the addition of dedicated process and analytical development laboratories. As a part of a capital investment of approximately 13 billion yen (approx. $120 million USD) in the gene therapy field by Fujifilm Corporation, an investment of approximately $55 million USD will be made to establish a new Gene Therapy Innovation Center adjacent to FDB’s existing state-of-the-art cGMP gene therapy manufacturing facility in College Station, TX and forms part of the company’s strategy to meet the growing demands in the viral gene therapy market. The gene therapy market forecast for CDMOs is expected to grow to $1.7 billion by 2025, according to market research conducted by Fujifilm.
     
    The Gene Therapy Innovation Center will be approximately 60,000 square feet and will house state-of-the-art upstream, downstream and analytical development technologies. The facility will be operational in the fall of 2021.
     
    “We are very much aware of the incredible growth in such an important therapeutic space,” said Martin Meeson, president and chief operating officer of Fujifilm Diosynth Biotechnologies, US. “We know that we need to invest now, in technology, assets and people in order to achieve a market leadership position. The expansion through the construction of the Gene Therapy Innovation Center demonstrates our ongoing commitment for growth.”
     
    FDB’s main goals behind this new strategy are to provide leading, future proofed end-to-end gene therapy solutions, from pre-clinical to commercial launch. This follows an earlier announcement made by FDB to introduce its gene therapy fill finish services.
     
    “We expect to break ground in the first quarter of 2020,” said Gerry Farrell, chief operating officer at Fujifilm Diosynth Biotechnologies, Texas. “his new facility will triple our gene therapy development capabilities and will add approximately 100 jobs to our Texas Campus.”
    Related Searches
    • CDMO
    • www.contractpharma.com
    • facility
    • end-to-end
    Suggested For You
    CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
    Contract Pharma’s 20th Anniversary Series: CDMO Insight Contract Pharma’s 20th Anniversary Series: CDMO Insight
    Fujifilm Eyes Being ‘Total Healthcare Company’ Fujifilm Eyes Being ‘Total Healthcare Company’
    Fighting Back! Fighting Back!
    LSNE LSNE's Spain Site Gets FDA Approval
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Highly Potent Expansions Highly Potent Expansions
    Upperton Pharma Solutions Investment Increases Tabletting Capabilities Upperton Pharma Solutions Investment Increases Tabletting Capabilities
    Bora Secures FDA Approval for CDMO Services Bora Secures FDA Approval for CDMO Services
    Preparing for Your CDMO Selection Process Preparing for Your CDMO Selection Process
    Fujifilm Completes Acquisition of Biogen’s Manufacturing Site in Denmark Fujifilm Completes Acquisition of Biogen’s Manufacturing Site in Denmark
    Regis Technologies Expands Capabilities Regis Technologies Expands Capabilities
    FUJIFILM Irvine Scientific to Construct Manufacturing Site in Europe FUJIFILM Irvine Scientific to Construct Manufacturing Site in Europe
    Fujifilm to Invest $10M in Continuous Processing Facility Fujifilm to Invest $10M in Continuous Processing Facility
    Fujifilm Opens Life Science Office in Massachusetts Fujifilm Opens Life Science Office in Massachusetts

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sanofi Awarded $226M by US Gov

      Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

      U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.
      Sanofi 12.13.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Avantor Boosts Biopharmaceutical Innovation in China

      Avantor Boosts Biopharmaceutical Innovation in China

      Opens innovation and customer support center in Shanghai.
      12.11.19

    • Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
      Charles River, Bit Bio Enter Strategic Pact

      Charles River, Bit Bio Enter Strategic Pact

      Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale
      12.10.19


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract

      Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract

      To increase domestic pandemic influenza vaccine production capabilities in Swiftwater, PA
      12.09.19

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sartorius Expands Cell Culture Media Capabilities

      Sartorius Expands Cell Culture Media Capabilities

      Pays $45 million for a majority stake in cell culture media specialist Biological Industries.
      12.09.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      WuXi Biologics Makes Second Major Investment in Ireland

      WuXi Biologics Makes Second Major Investment in Ireland

      To build a $240 million vaccine manufacturing facility on its Dundalk site.
      12.09.19


    • Biologics, Proteins, Vaccines | Breaking News | Industry News

      Novasep Launches oXYgene for Boosting Viral Vector Production

      A unique 2-year turnkey plant offer to accelerate commercial production of viral vectors.
      12.05.19

    • Aseptic Processing | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Polyplus-transfection Expands GMP Portfolio

      Polyplus-transfection Expands GMP Portfolio

      New GMP conditioning of PEIpro-GMP designed to support clinical phase and commercialization stages of production
      12.03.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      3P Bio, In3Bio Enter Cancer Pact

      3P Bio, In3Bio Enter Cancer Pact

      New anti-tumor treatment is one step closer to the clinic on heels of new collaboration.
      11.28.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Lonza and DiNAQOR AG Enter Gene Therapy Collaboration

      Lonza and DiNAQOR AG Enter Gene Therapy Collaboration

      Lonza’s manufacturing site in Houston, TX will handle all product supply for DiNA-001.
      11.28.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
      Novartis to Acquire The Medicines Company for $9.7B

      Novartis to Acquire The Medicines Company for $9.7B

      Adds cardiovascular drug inclisiran to portfolio, a potentially transformational investigational cholesterol-lowering therapy.
      11.28.19

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      Dedicated facility will supply a vaccine product of a large global pharma for the global market
      11.25.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Navrogen, Lonza Enter Bio Production Deal

      Navrogen, Lonza Enter Bio Production Deal

      Sign agreement to use Lonza’s GS Gene Expression System for Navrogen’s anti-HIO targeting agents.
      11.22.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      HALIX Opens State-of-the-Art cGMP Facility

      HALIX Opens State-of-the-Art cGMP Facility

      New facility for the development and manufacturing of biopharmaceuticals.
      11.22.19

    • Biologics, Proteins, Vaccines | Breaking News | Industry News | Toxicology
      WuXi AppTec’s Lab Testing Division Expands in Suzhou

      WuXi AppTec’s Lab Testing Division Expands in Suzhou

      Increases toxicology capacity by 80% to execute full-service preclinical and clinical safety assessments for biologics and small molecules
      11.19.19

    Breaking News
    • Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    • Amgen Selects Location For R&D Facility
    • Arctoris Opens Oxford R&D Facility
    • Almac Group, Exostar Collaborate on IRT Experience
    • Northwest Biotherapeutics Expands Management Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    • Transitioning from Clinical Production to Commercial Manufacturing
    • Clinical Trial Technology
    • Regenerative Medicine: Overcoming the supply chain challenges
    • The Future of the Pharmaceutical Supply Chain
    • Challenges and Opportunities in Vaccines Drug Development
    • Managing Partnerships: Sponsors & CDMOs
    • Towards Sunset or a New Dawn?
    • Biopharma Over 20 Years
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.